DISCONTINUOUS ECULIZUMAB THERAPY IN AN ATYPICAL HEMOLYTIC UREMIC SYNDROME WITH COMPLEMENT FACTOR H MUTATION
PEDIATRIC NEPHROLOGY（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined